In the other case report, a 62-year-old patient with colorectal cancer exhibiting multi-organ metastases was administered EGF eye drops (0.05 mg/ml, 8/day) to treat binocular refractory corneal epithelial defects during cetuximab treatment. This evidence concerns the gene EGF and colorectal cancer.